Amaurosis Fugax · What Is It, Causes, and More

Published: Jul 30, 2025
Author: Nikol Natalia Armata, MD
Editor: Alyssa Haag, MD
Editor: Ian Mannarino, MD, MBA
Editor: Anna Hernández, MD
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Jillian Dunbar
Copyeditor: Sadia Zaman, MBBS, BSc
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What is amaurosis fugax?

Amaurosis fugax, literally ‘dark fleeting’, refers to a sudden, short-term, painless loss of vision in one eye. It’s also known as a retinal transient ischemic attack (TIA). The loss of vision occurs most commonly in adults over 50 and typically lasts for a few minutes. The symptom is sometimes associated with thrombotic vascular events originating from the internal carotid arteries and is therefore considered a possible warning sign for an impending stroke 

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

Is amaurosis fugax an emergency?

Amaurosis fugax is considered a medical emergency and requires immediate investigation of the underlying cause. 

What causes amaurosis fugax?

Typically, amaurosis fugax is the result of narrowing or occlusion of the internal carotid artery or the central retinal artery, leading to decreased blood supply to the retina, optic nerve, or other visual pathways. One of the most common causes of amaurosis fugax is carotid artery disease, where fatty deposits called plaques narrow the blood vessels that deliver blood to the brain. Sometimes, parts of the plaque can detach from the inner lining of the artery and clog smaller blood vessels, such as the central retinal artery.   

Amaurosis fugax can also occur as a symptom of other underlying conditions. For example, transient monocular visual loss can be caused by inflammation of the optic nerve, called optic neuritis; demyelinating disorders, like multiple sclerosis; or severe head injuries. Individuals older than 60 years of age that have had multiple episodes of transient monocular blindness could also be investigated for giant cell arteritis, which is characterized by inflammation of the large vessels of the scalp, neck, and arms. Transient vision loss may also be a sign of visual aura in individuals with migraine headaches. 

Several risk factors have been associated with amaurosis fugax. Diabetes, and tobacco and cocaine use can have long-term complications affecting the small blood vessels supplying the retina. Individuals reaching an advanced age also may be more likely to experience amaurosis fugax due to higher rates of high blood pressure and hyperlipidemia (i.e., high levels of lipids in the blood), which increases the risk of carotid artery disease.  

What are the signs and symptoms of amaurosis fugax?

Amaurosis fugax presents with very characteristic visual symptoms; most individuals describe their experience as a “curtain passing across the eye” that ultimately blocks their vision. The extent to which the eye’s visual field is affected varies; the entire field or only part of it may be affected. Visual loss is often painless and tends to last only for a few seconds to minutes. Individuals may experience one or multiple episodes that typically resolve on their own, but rarely they may progress to permanent loss of vision

How is amaurosis fugax diagnosed?

Diagnosis of amaurosis fugax begins by obtaining a medical history and assessment of any vascular risk factors present. Individuals are typically investigated for hypertension, diabetes, hyperlipidemia, and cardiac disease, and may be asked about other risk factors like tobacco use. A detailed physical assessment, including a complete eye exam with pupil dilation may be performed to assess the optic nerve and optic disc. Additionally, auscultation of the carotid arteries and the heart may be performed. Further blood tests, including inflammatory blood markers (e.g., ESR, CRP) may also be obtained to rule out giant cell arteritis  

If carotid artery disease is suspected, a Doppler ultrasound can be used to identify plaque build-up in the internal carotid arteries. Neuroimaging tests, such as magnetic resonance and computed tomography (CT) angiography, may also be perfomed to evaluate blood flow to the brain’s arteries and detect any occlusions. 

How is amaurosis fugax treated?

Treatment of amaurosis fugax depends on the underlying cause. In cases of carotid artery disease, management is aimed at controlling and treating the underlying vascular risk factors, such as hypertension, diabetes, and hyperlipidemia. Most individuals are recommended antiplatelet therapy with aspirin to reduce the risk of stroke. Asymptomatic individuals with severe carotid stenosis may benefit from carotid stenting, a minimally invasive technique used to prop the artery open and stabilize the plaque. More invasive techniques, including carotid endarterectomy, which is surgical removal of the vessel blockage, are typically reserved for individuals with symptoms or severe carotid stenosis. 

What are the most important facts to know about amaurosis fugax?

Amaurosis fugax refers to a sudden, short-term, usually painless loss of vision in one eye. It’s usually caused by atherosclerotic emboli that leads to retinal artery occlusion. There are many risk factors associated with amaurosis fugax, including diabetes, hyperlipidemia as well as tobacco useVisual symptoms associated with this condition include unilateral, painless loss of vision  that resolves spontaneously within a few minutes. Diagnosis relies on a detailed medical history and eye exam, as well as imaging such as Doppler ultrasound or angiography. Treating the underlying risk factors as well as administering antiplatelet therapy is crucial to prevent more serious complications like a stroke or permanent vision loss. In severe cases, surgical procedures such as carotid stenting or carotid endarterectomy may be necessary.  

Key Takeaways

Definition 

Transient monocular visual loss, also known as retinal transient ischemic attack. Possible warning sign for an impending stroke 

Causes 

- Narrowing or occlusion of the internal carotid artery or central retinal artery, usually due to carotid artery disease 

- Optic neuritis 

- Demyelinating disorders (e.g., multiple sclerosis 

- Severe head injury 

- Giant cell arteritis 

- Migraines 

Signs and Symptoms 

- Visual loss in part of or the entire visual field 

- Few seconds to minutes 

- Usually self-resolving, rarely permanent 

Diagnosis 

- Medical history 

- Risk factors assessment 

- Eye exam with pupil dilation  

- Auscultation of carotid arteries and heart 

- Blood tests 

- Doppler ultrasound of carotid arteries 

- Brain MRI or CT angiography 

Treatment 

- Address underlying risk factors 

- Antiplatelet therapy (e.g., aspirin 

- Carotid stenting  

- Carotid endarterectomy 

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


Dattilo M, Newman NJ, Biousse V. Acute retinal arterial ischemia. Ann Eye Sci. 2018;3(6):28-28. doi:10.21037/aes.2018.05.04  


Douglas VP, Rachapudi SS, Davila-Siliezar P, Laylani NAR, Lee AG. Transient monocular visual loss (amaurosis fugax): How does age impact diagnosis? Ophthalmol Ther. 2024;13(6):1417-1425. doi:10.1007/s40123-024-00932-z 


Martinez-Viguera A, Xuclà-Ferrarons T, Collet R, et al. Clinical characteristics and outcome of amaurosis fugax due to transient retinal ischemia: Results from a contemporary cohort. J Stroke Cerebrovasc Dis. 2023;32(11):107335. doi:10.1016/j.jstrokecerebrovasdis.2023.107335  


Mbonde AA, O’Carroll CB, Dulamea OA, Anghel D, Chong BW, Dumitrascu OM. Current guidelines on management of amaurosis fugax and transient ischemic attacks. Asia Pac J Ophthalmol (Phila). 2022;11(2):168-176. doi:10.1097/APO.0000000000000511